Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: A population-based study from China

Annals of Surgical Oncology

Volumn 19, Issue 9, 2012, Pages 3019-3027

  Cao, A Yong ^a   He, Min ^a   Liu, Zhe Bin ^a   Di, Gen Hong ^a   Wu, Jiong ^a   Lu, Jin Song ^a   Liu, Guang Yu ^a   Shen, Zhen Zhou ^a   Shao, Zhi Ming ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHINA; CLINICAL FEATURE; COLLOID CARCINOMA; COMPARATIVE STUDY; FEMALE; GENE OVEREXPRESSION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS FREE SURVIVAL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PHENOTYPE; PROTEIN EXPRESSION; PURE MUCINOUS BREAST CARCINOMA; RECURRENCE FREE SURVIVAL; REFERENCE DATABASE; RELIABILITY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; CHINA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84867399030     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2322-6     Document Type: Article

References (27)

1. Komaki K, Sakamoto G, Sugano H, Morimoto T, Monden Y. Mucinous carcinoma of the breast in Japan. A prognostic analysis based on morphologic features. Cancer. 1988;61:989-96.
2. André S, Cunha F, Bernardo M, Meneses e Sousa J, Cortez F, Soares J. Mucinous carcinoma of the breast: a pathologic study of 82 cases. J Surg Oncol. 1995;58:162-7.
3. Diab SG, Clark GM, Osborne CK, Libby A, Allred DC, Elledge RM. Tumor characteristics and clinical outcome of tubular and mucinous breast carcinomas. J Clin Oncol. 1999;17:1442-8.
4. Hanagiri T, Ono K, Baba T, et al. Clinicopathologic characteristics of mucinous carcinoma of the breast. Int Surg. 2010;95:126-9.
5. Domoto H, Terahata S, Yamazaki T, Sato K, Takeo H, Tamai S. Mucinous cystadenocarcinoma of the breast showing sulfomucin production. Histopathology. 2000;36:567-9.
6. Chen WY, Chen CS, Chen HC, Hung YJ, Chu JS. Mucinous cystadenocarcinoma of the breast coexisting with infiltrating ductal carcinoma. Pathol Int. 2004;54:781-6.
7. Rasmussen BB. Human mucinous breast carcinomas and their lymph node metastases. A histological review of 247 cases. Pathol Res Pract. 1985;180:377-82.
8. Lee SH, Chaung CR. Mucinous metaplasia of breast carcinoma with macrocystic transformation resembling ovarian mucinous cystadenocarcinoma in a case of synchronous bilateral infiltrating ductal carcinoma. Pathol Int. 2008;58:601-5.
9. Rasmussen BB, Rose C, Christensen IB. Prognostic factors in primary mucinous breast carcinoma. Am J Clin Pathol. 1987;87:155-60.
10. Avisar E, Khan MA, Axelrod D, Oza K. Pure mucinous carcinoma of the breast: a clinicopathologic correlation study. Ann Surg Oncol. 1998;5:447-51.
11. Barkley CR, Ligibel JA, Wong JS, Lipsitz S, Smith BL, Golshan M. Mucinous breast carcinoma: a large contemporary series. Am J Surg. 2008;196:549-51.
12. Fentiman IS, Millis RR, Smith P, Ellul JP, Lampejo O. Mucoid breast carcinomas: histology and prognosis. Br J Cancer. 1997;75:1061-5.
13. Yoneyama F, Tsuchie K, Sakaguchi K. Massive mucinous carcinoma of the breast untreated for 6 years. Int J Clin Oncol. 2003;8:121-3.
14. Cao AY, Hu Z, Shao ZM. Mutation screening of breast cancer susceptibility genes in Chinese high-risk families: the results will develop the genetic testing strategy in China. Breast Cancer Res Treat. 2010;120:271-2.
15. Fan L, Zheng Y, Yu KD, et al. Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat. 2009;117:409-16.
16. World Health Organization. Histological typing of breast tumors. Tumori. 1982;68:181-98.
17. Dhillon R, Depree P, Metcalf C, Wylie E. Screen-detected mucinous breast carcinoma: potential for delayed diagnosis. Clin Radiol. 2006;61:423-30.
18. Matsuda M, Yoshimoto M, Iwase T, et al. Mammographic and clinicopathological features of mucinous carcinoma of the breast. Breast Cancer. 2000;7:65-70.
19. Zonderland HM. The role of ultrasound in the diagnosis of breast cancer. Semin Ultrasound CT MR. 2000;21:317-24.
20. Monzawa S, Yokokawa M, Sakuma T, et al. Mucinous carcinoma of the breast: MRI features of pure and mixed forms with histopathologic correlation. AJR Am J Roentgenol. 2009;192:W125-31.
21. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology. 2001;220:13-30.
22. Okafuji T, Yabuuchi H, Sakai S, et al. MR imaging features of pure mucinous carcinoma of the breast. Eur J Radiol. 2006;60:405-13.
23. Di Saverio S, Gutierrez J, Avisar E. A retrospective review with long term follow up of 11, 400 cases of pure mucinous breast carcinoma. Breast Cancer Res Treat. 2008;111:541-7.
24. Park S, Koo J, Kim JH, Yang WI, Park BW, Lee KS. Clinicopathological characteristics of mucinous carcinoma of the breast in Korea: comparison with invasive ductal carcinoma-not otherwise specified. J Korean Med Sci. 2010;25:361-8.
25. Paramo JC, Wilson C, Velarde D, Giraldo J, Poppiti RJ, Mesko TW. Pure mucinous carcinoma of the breast: is axillary staging necessary? Ann Surg Oncol. 2002;9:161-4.
26. Thurman SA, Schnitt SJ, Connolly JL, et al. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma. Int J Radiat Oncol Biol Phys. 2004;59:152-9.
27. Vo T, Xing Y, Meric-Bernstam F, et al. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg. 2007;194:527-31.